Anaplastic Large-Cell Lymphoma (ALCL) is a rare and aggressive form of non-Hodgkin lymphoma that primarily impacts T-cells, a crucial part of the immune system.

20. Dashevsky BZ, Gallagher KM, Grabenstetter A, et al. breast implant†associated anaplastic large-cell lymphoma: clinical and imaging findings at a large US cancer center.

Therapeutics Market is projected to experience robust growth, expanding from USD 12.2 billion in 2025 to USD 19.9 billion by ...

Columbia University investigators report an increased risk of breast lymphomas after postmastectomy implant-based reconstruction, including anaplastic large-cell lymphoma and several B-cell and T ...

The agency said at least 457 women in the U.S. have been diagnosed with anaplastic large cell lymphoma. Nine of them have died.

This study provides the first epidemiologic data to confirm elevated risks for any subtype other than anaplastic large-cell lymphoma (ALCL), a rare form of cancer first linked to breast implants ...

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T‐cell lymphoma that emerges in the periprosthetic capsule surrounding breast implants, particularly those with a ...

The FDA is warning about a rare and deadly cancer linked to breast implants.